SB773812
Sponsors
GlaxoSmithKline
Conditions
Schizophrenia
Phase 1
In-Patient Study In Schizophrenic Patients
CompletedNCT00197093
Start: 2004-09-30Target: 60Updated: 2009-05-18
SPECT Study With SB-773812 In Schizophrenic Patients
CompletedNCT00269035
Start: 2005-06-21End: 2007-05-26Updated: 2017-08-17
Effects Of The Drug Ketoconazole On How The Body Handles The Drug SB773812
CompletedNCT00411866
Start: 2006-10-13End: 2007-10-10Updated: 2017-08-03